FORZINITY (ELAMIPRETIDE HCI) INJECTION
NOTICE OF ALLOWANCE – ISSUEDCombined Mark
Never miss important updates for FORZINITY (ELAMIPRETIDE HCI) INJECTION
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Key Information
Ownership
SB
Address
123 Highland Ave, Suite 201
Needham, MA 02494
Critical Dates
First Use Date
Not filed yet
Filing Date
Mar 17, 2025
Publication Date
Dec 23, 2025
Mark Descriptions
Goods
Class 5
Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders...
Mark Elements
Text Mark
FORZINITY (ELAMIPRETIDE HCI) INJECTION
Category
Trademark
Standard Characters
No
Color Claim
No
Design Search Codes
260515
260521
260528
261313
261321
Trademark Timeline
Filing Date
Publication Date
USPTO Records
No documents found for this trademark.